1-[2-Amino-4-(4-chlorophenyl)pyrimidin-5-yl]-1,2-dihydropyridin-2-one

Catalog No. :
ACRPGT950
CAS No. :
339020-91-6
Molecular Formula :
C15H11ClN4O
Molecular Weight :
298.73

IUPAC Name:1-(2-amino-4-(4-chlorophenyl)pyrimidin-5-yl)pyridin-2(1H)-one

1-[2-Amino-4-(4-chlorophenyl)pyrimidin-5-yl]-1,2-dihydropyridin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$284.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[2-Amino-4-(4-chlorophenyl)pyrimidin-5-yl]-1,2-dihydropyridin-2-one
IUPAC Name1-(2-amino-4-(4-chlorophenyl)pyrimidin-5-yl)pyridin-2(1H)-one
MDL No.MFCD00232178
Molecular FormulaC15H11ClN4O
Molecular Weight298.73
SMILESO=C1C=CC=CN1C2=CN=C(N)N=C2C3=CC=C(Cl)C=C3
InChI KeyMAVJZCBJMZHMNP-UHFFFAOYSA-N
Synonym1-[2-AMINO-4-(4-CHLOROPHENYL)-5-PYRIMIDINYL]-2(1H)-PYRIDINONE;1-[2-amino-4-(4-chlorophenyl)pyrimidin-5-yl]-1,2-dihydropyridin-2-one;2(1H)-Pyridinone, 1-[2-amino-4-(4-chlorophenyl)-5-pyrimidinyl]-
CAS No.339020-91-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACRPGT950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACABXR840 route compound structure diagram
    ACABXR84050979-18-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPGT950 route product structure diagram
    ACRPGT950339020-91-6
Inquiry

2. ACRPGT950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACRPGT950 route product structure diagram
    ACRPGT950339020-91-6
Inquiry

Comments (0)